Trial intelligence / Profile preview

Caudal Block in Anal Sphincter Sparing Procedures

NCT04651595Completed

Sponsor
Kasr Al Ainy Hospital
Start
Jan 2021
Primary completion
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of bupivacaine in anal fistula (2 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Time to first request of rescue postoperative analgesic at 24 hours. Started Jan 2021; status: completed.

02

Drugs

bupivacaine
03

Conditions

anal fistula

Beyond the preview

Go deeper on NCT04651595.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04651595.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call